Cargando…
Drugs prescribed for Phelan-McDermid syndrome differentially impact sensory behaviors in shank3 zebrafish models.
Background: Altered sensory processing is a pervasive symptom in individuals with Autism Spectrum Disorders (ASD); people with Phelan McDermid syndrome (PMS), in particular, show reduced responses to sensory stimuli. PMS is caused by deletions of the terminal end of chromosome 22 or point mutations...
Autores principales: | Kozol, Robert A., Dallman, Julia E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589628/ https://www.ncbi.nlm.nih.gov/pubmed/37868296 http://dx.doi.org/10.12688/f1000research.127830.2 |
Ejemplares similares
-
Understanding Behavior in Phelan-McDermid Syndrome
por: Landlust, Annemiek M., et al.
Publicado: (2022) -
Characterisation of the clinical phenotype in Phelan-McDermid syndrome
por: Burdeus-Olavarrieta, Mónica, et al.
Publicado: (2021) -
Delineation of the genetic and clinical spectrum of Phelan-McDermid syndrome caused by SHANK3 point mutations
por: De Rubeis, Silvia, et al.
Publicado: (2018) -
Parent-reported measure of repetitive behavior in Phelan-McDermid syndrome
por: Srivastava, Siddharth, et al.
Publicado: (2021) -
Sensory Reactivity Phenotype in Phelan–McDermid Syndrome Is Distinct from Idiopathic ASD
por: Tavassoli, Teresa, et al.
Publicado: (2021)